Cardioprotection by volatile anesthetics.

Area of Science:

• Cardiology
• Anesthesiology
• Biochemistry

Background:

• The heart has endogenous mechanisms for protection against ischemia and reperfusion injury, known as preconditioning.
• Volatile anesthetics can induce a similar cardioprotective effect, reducing myocardial infarct size.
• Shared signaling pathways exist between anesthetic and ischemic preconditioning.

Purpose of the Study:

• To review recent advancements in understanding how volatile anesthetics provide cardioprotection.
• To explore the mechanisms underlying anesthetic-induced cardioprotection.
• To highlight the clinical relevance of volatile anesthetic preconditioning.

Main Methods:

• Review of existing literature on volatile anesthetics and cardioprotection.
• Analysis of signal transduction pathways involved in myocardial protection.
• Examination of reactive oxygen species (ROS) generation by anesthetics.
• Evaluation of clinical studies on anesthetic preconditioning in cardiac surgery.

Main Results:

• Volatile anesthetics trigger cardioprotection by generating reactive oxygen species (ROS).
• Key signaling molecules include G-protein-coupled receptors, protein kinases, and mitochondrial ATP-sensitive potassium (K(ATP)) channels.
• Anesthetic preconditioning reduces myocardial infarct size comparably to ischemic preconditioning.
• Clinical evidence suggests beneficial effects in patients undergoing cardiac surgery.

Conclusions:

• Volatile anesthetics offer a powerful preconditioning strategy for cardiac protection.
• The cardioprotective effects involve ROS generation and activation of conserved signaling pathways.
• Anesthetic preconditioning holds significant promise for improving outcomes in cardiac surgery patients.